Scarica l'app Stockscreener
1.51
9.04%
-0.15
Precedente Chiudi:
$1.66
Aprire:
$1.67
Volume 24 ore:
71,767
Relative Volume:
0.03
Capitalizzazione di mercato:
$6.79M
Reddito:
$9.37M
Utile/perdita netta:
$-8.45M
Rapporto P/E:
-1.8642
EPS:
-0.81
Flusso di cassa netto:
$-7.27M
1 W Prestazione:
-7.36%
1M Prestazione:
-29.77%
6M Prestazione:
-83.50%
1 anno Prestazione:
-94.83%
Intervallo 1D:
$1.48
$1.68
Intervallo di 1 settimana:
$1.48
$1.74
Portata 52W:
$1.25
$46.53
Bioaffinity Technologies Inc Stock (BIAF) Company Profile
Nome
Bioaffinity Technologies Inc
Settore
Industria
Telefono
210-698-5334
Indirizzo
3300 NACOGDOCHES ROAD, SAN ANTONIO
Confronta BIAF con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BIAF
Bioaffinity Technologies Inc
|
1.51 | 7.47M | 9.37M | -8.45M | -7.27M | -0.81 |
|
TMO
Thermo Fisher Scientific Inc
|
572.28 | 217.50B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
226.33 | 164.13B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
704.20 | 56.49B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
139.68 | 40.44B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
222.26 | 38.48B | 15.90B | 1.28B | 2.21B | 7.2842 |
Bioaffinity Technologies Inc Borsa (BIAF) Ultime notizie
Reviewing bioAffinity Technologies (NASDAQ:BIAF) and Briacell Therap (NASDAQ:BCTX) - Defense World
bioAffinity Technologies Inc. (BIAF) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Why bioAffinity Technologies Inc. stock could outperform in 2025Trade Risk Assessment & Growth Oriented Trading Recommendations - Newser
bioAffinity Technologies’ Noninvasive CyPath® Lung Test to Be Highlighted at American Cancer Society - PharmiWeb.com
bioAffinity Technologies’ Noninvasive CyPath® Lung Test to Be Highlighted at American Cancer Society National Lung Cancer Roundtable - BioSpace
bioAffinity Technologies to Present at Cancer Roundtable - TipRanks
bioAffinity Technologies, Inc. to Present CyPath® Lung Test at ACS Roundtable - TradingView
Certain Warrants of bioAffinity Technologies, Inc. are subject to a Lock-Up Agreement Ending on 30-NOV-2025. - marketscreener.com
Certain Convertible Preferred Stock of bioAffinity Technologies, Inc. are subject to a Lock-Up Agreement Ending on 30-NOV-2025. - marketscreener.com
1,375,102 Common Stock of bioAffinity Technologies, Inc. are subject to a Lock-Up Agreement Ending on 30-NOV-2025. - marketscreener.com
bioAffinity Technologies Inc trading halted, volatility trading pause - MSN
WallachBeth Capital Announces The Closing of bioAffinity Technologies $1.8M Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules (PR Newswire) - Aktiellt
Aug Action: Why bioAffinity Technologies Inc. stock could be next big winner - BỘ NỘI VỤ
bioAffinity Technologies Reports Strong Growth in Lung Test Revenue - MSN
How bioAffinity Technologies Inc. stock benefits from global expansionGDP Growth & Fast Exit Strategy with Risk Control - moha.gov.vn
Investment Review: Why retail investors pile into bioAffinity Technologies Inc. stockJuly 2025 Analyst Calls & Risk Controlled Daily Trade Plans - moha.gov.vn
Earnings roundup: Q3 rocky for bioAffinity and Spurs concessionaire - San Antonio Express-News
Is bioAffinity Technologies Inc Equity Warrant a good long term investmentMean Reversion Trades & Rapid Portfolio Gain - earlytimes.in
BIAF Stock Dips After Q3 Earnings Reflect Lower Sales and Wider Loss - MSN
bioAffinity Technologies Reports Surge in CyPath® Lung Tests - MSN
How bioAffinity Technologies Inc. stock benefits from tech adoptionJuly 2025 Momentum & Weekly Breakout Stock Alerts - newser.com
Is bioAffinity Technologies Inc. stock cheap compared to fundamentalsTrade Volume Summary & Weekly Stock Breakout Alerts - newser.com
Will bioAffinity Technologies Inc. stock deliver strong dividend growthWeekly Volume Report & Real-Time Market Sentiment Reports - newser.com
Will bioAffinity Technologies Inc. stock recover faster than marketJuly 2025 Update & AI Optimized Trading Strategy Guides - newser.com
Is bioAffinity Technologies Inc. stock a buy for dividend growth2025 Short Interest & Accurate Technical Buy Alerts - newser.com
Volume spikes in bioAffinity Technologies Inc. Equity Warrant stock – what they mean2025 Volatility Report & Growth Focused Entry Point Reports - newser.com
Is bioAffinity Technologies Inc. meeting your algorithmic filter criteriaProduct Launch & Fast Exit and Entry Strategy Plans - newser.com
Is bioAffinity Technologies Inc. stock oversold or undervaluedTrade Exit Summary & AI Based Buy and Sell Signals - newser.com
Maxim Group Sticks to Its Buy Rating for bioAffinity Technologies, Inc. (BIAF) - The Globe and Mail
Will bioAffinity Technologies Inc. Equity Warrant benefit from macro trendsPortfolio Return Report & AI Enhanced Execution Alerts - newser.com
Why bioAffinity Technologies Inc. stock is seen as undervalued2025 Institutional Moves & Verified Swing Trading Watchlists - newser.com
Will bioAffinity Technologies Inc. stock see insider buying2025 Top Gainers & Technical Confirmation Trade Alerts - newser.com
What recovery options are there for bioAffinity Technologies Inc.2025 Sector Review & Fast Exit/Entry Strategy Plans - newser.com
Is bioAffinity Technologies Inc. stock attractive for retirement portfoliosJuly 2025 News Drivers & Low Drawdown Momentum Trade Ideas - newser.com
Using data filters to optimize entry into bioAffinity Technologies Inc. Equity WarrantJuly 2025 PreEarnings & Reliable Intraday Trade Alerts - newser.com
MSN Money - MSN
Is bioAffinity Technologies Inc. stock attractive for growth ETFs2025 Historical Comparison & Free Growth Oriented Trading Recommendations - newser.com
Can momentum traders help lift bioAffinity Technologies Inc. Equity WarrantMarket Movement Recap & Daily Chart Pattern Signal Reports - newser.com
Will bioAffinity Technologies Inc. Equity Warrant stock outperform Dow Jones indexMarket Activity Report & High Accuracy Investment Signals - newser.com
Bioaffinity Technologies Inc Azioni (BIAF) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.15%
0.39%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):